Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles

Journal of Neuropathology and Experimental Neurology

Volumn 61, Issue 6, 2002, Pages 557-564

  Augustinack, Jean C ^a   Sanders, Judith L ^a   Tsai, Li Huei ^a   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cdk5; Fluorescence resonance energy transfer (FRET); Hippocampus; Tau

Indexed keywords

CYCLIN DEPENDENT KINASE 5; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER GROWTH; NEUROFIBRILLARY TANGLE; PHOSPHORYLATION; PRIORITY JOURNAL; TEMPORAL LOBE;

EID: 0036275991     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/61.6.557     Document Type: Article

References (37)

1. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
2. The repeat region of microtubule-associated protein tau forms part of the core of the paired helical filament of Alzheimer's disease
3. The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease
4. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
5. Tau protein and the neurofibrillary pathology of Alzheimer's disease
6. Tau protein and the neurofibrillary pathology of Alzheimer's disease
7. On the structure of microtubules, tau, and paired helical filaments
8. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (cdk5) is degraded by the ubiquitin-proteasome pathway
9. Conversion of p35 to p25 deregulates cdk5 activity and promotes neurodegeneration
10. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration
11. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease
12. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
13. Neuropathological assessment of Alzheimer's disease: The experience of the Consortium to Establish a Registry for Alzheimer's Disease
14. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
15. Neuropathological stageing of Alzheimer-related changes
16. Lewy body dementia - Clinical, pathological and neurochemical interconnections
17. Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: Role of the intracellular adapter protein fe65
18. Demonstration by fluorescence resonance energy transfer of a close association between activated MAP kinase and neurofibrillary tangles: Implications for MAP kinase activation in Alzheimer disease
19. Alpha-synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies
20. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
21. Studies on the structure of the cerebral cortex
22. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease
23. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis
24. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
25. New fluorescent microscopical technique in diagnostic microbiology
26. Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: A fluorescence resonance energy transfer study
27. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments
28. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state
29. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation
30. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau
31. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells
32. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262
33. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption
34. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation
35. Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites
36. Interleukin-I promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: Potential significance for tau protein phosphorylation